Congruence Therapeutics

📍 Montreal, Canada🗓 Founded 2021👥 41 employees💰 Last funded Sep 2021
Biotechnology Research🌐 congruencetx.com
Website LinkedIn
Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our proprietary scalable platform, Revenir™, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Congruence Therapeutics?
Congruence Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Congruence Therapeutics last raise funding?
The most recent investment in Congruence Therapeutics recorded on gritt.io was in September 2021.
When was Congruence Therapeutics founded?
Congruence Therapeutics was founded in 2021.
What industry is Congruence Therapeutics in?
Congruence Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Congruence Therapeutics based?
Congruence Therapeutics is headquartered in Montreal, Canada.